期刊
CANCER LETTERS
卷 435, 期 -, 页码 92-100出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2018.08.006
关键词
Fatty acid beta-oxidation; Cancer; Lipolytic phenotype; ATP; NADPH
类别
资金
- DoD Breast Cancer Research Award [W81XWH-17-1-0317]
- Astar Biotechnology Research Award
- NIH [P30 CA16059]
- NATIONAL CANCER INSTITUTE [R01CA099326, P30CA016059, R01CA175033] Funding Source: NIH RePORTER
Cancer cells undergo metabolic reprogramming such as enhanced aerobic glycolysis, mutations in the beta-carboxylic acid cycle enzymes, and upregulation of de novo lipid synthesis and glutaminolysis. These alterations are pivotal to the development and maintenance of the malignant phenotype of cancer cells in unfavorable tumor microenvironment or metastatic sites. Although mitochondrial fatty acid beta-oxidation (FAO) is a primary bioenergetic source, it has not been generally recognized as part of the metabolic landscape of cancer. The last few years, however, have seen a dramatic change in the view of cancer relevance of the FAO pathway. Many recent studies have provided significant evidence to support a lipolytic phenotype of cancer. FAO, like other well-defined metabolic pathways involved in cancer, is dysregulated in diverse human malignancies. Cancer cells rely on FAO for proliferation, survival, sternness, drug resistance, and metastatic progression. FAO is also reprogrammed in cancer-associated immune and other host cells, which may contribute to immune suppression and tumor-promoting microenvironment. This article reviews and puts into context our current understanding of multi-faceted roles of FAO in oncogenesis as well as anti-cancer therapeutic opportunities posed by the FAO pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据